Nancy J Hutson Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Nancy J Hutson.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Nancy J Hutson. Nancy J Hutson is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in INSPIRE PHARMACEUTICALS INC ($ISPH) and Director in PhaseBio Pharmaceuticals Inc ($PHAS) and Director in Clearside Biomedical, Inc. ($CLSD) and Director in Endo International plc ($ENDP).
Latest Insider Trading Transactions of Nancy J Hutson
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BCRX, CLSD, ENDP, ISPH, PHAS
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 3.11 | 25,000 | 77,750 | 25,000 | |
Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 15 2021 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 3.11 | 5,000 | 15,525 | 10,000 | 5 K to 10 K (+100.00 %) |
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.78 | 463 | 4,991 | 64,756 | 64.3 K to 64.8 K (+0.72 %) |
Mar 02 2021 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.78 | 463 | 4,991 | 64,756 | 64.3 K to 64.8 K (+0.72 %) |
Dec 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.11 | 978 | 4,998 | 64,293 | 63.3 K to 64.3 K (+1.54 %) |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.15 | 1,204 | 4,997 | 63,315 | 62.1 K to 63.3 K (+1.94 %) |
Sep 02 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.15 | 1,204 | 4,997 | 63,315 | 62.1 K to 63.3 K (+1.94 %) |
Jun 19 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 2.00 | 25,000 | 50,000 | 25,000 | |
Jun 16 2020 | ENDP | Endo International ... | Hutson Nancy J | Director | Payment of Exercise | F | 3.43 | 12,245 | 42,000 | 91,219 | 103.5 K to 91.2 K (-11.84 %) |
Jun 16 2020 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 25,511 | 0 | 103,464 | 78 K to 103.5 K (+32.73 %) |
Jun 05 2020 | PHAS | PhaseBio Pharmaceu ... | Hutson Nancy J | Director | Option Exercise | A | 4.86 | 16,000 | 77,760 | 16,000 | |
May 21 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Buy | P | 1.85 | 5,000 | 9,250 | 5,000 | 0 to 5 K |
May 14 2020 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 5.41 | 40,000 | 216,400 | 40,000 | |
Apr 23 2020 | CLSD | Clearside Biomedic ... | Hutson Nancy J | Director | Option Exercise | A | 2.09 | 30,000 | 62,700 | 30,000 | |
Dec 03 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 2.85 | 3,508 | 9,998 | 56,554 | 53 K to 56.6 K (+6.61 %) |
Nov 18 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Buy | P | 1.45 | 10,000 | 14,500 | 53,046 | 43 K to 53 K (+23.23 %) |
Sep 04 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 2.99 | 3,344 | 9,999 | 43,046 | 39.7 K to 43 K (+8.42 %) |
Jun 14 2019 | ENDP | Endo International ... | Hutson Nancy J | Director | Payment of Exercise | F | 4.46 | 25,829 | 115,197 | 77,953 | 103.8 K to 78 K (-24.89 %) |
Jun 14 2019 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 53,812 | 0 | 103,782 | 50 K to 103.8 K (+107.69 %) |
May 31 2019 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 2.91 | 30,000 | 87,300 | 30,000 | |
May 13 2019 | PHAS | PhaseBio Pharmaceu ... | Hutson Nancy J | Director | Option Exercise | A | 13.23 | 11,000 | 145,530 | 11,000 | |
Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Hutson Nancy J | Director | Option Exercise | A | 3.15 | 8,900 | 28,035 | 8,900 | |
Mar 01 2019 | PHAS | PhaseBio Pharmaceu ... | Hutson Nancy J | Director | Option Exercise | A | 3.15 | 8,900 | 28,035 | 8,900 | |
Dec 17 2018 | PHAS | PhaseBio Pharmaceu ... | Hutson Nancy J | Director | Buy | P | 4.46 | 1,000 | 4,460 | 1,000 | 0 to 1,000 |
Nov 16 2018 | ENDP | Endo International ... | Hutson Nancy J | Director | Sell | S | 12.83 | 10,000 | 128,300 | 49,970 | 60 K to 50 K (-16.68 %) |
Jun 22 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 6.09 | 30,000 | 182,700 | 30,000 | |
Jun 12 2018 | ENDP | Endo International ... | Hutson Nancy J | Director | Payment of Exercise | F | 7.67 | 15,019 | 115,196 | 59,970 | 75 K to 60 K (-20.03 %) |
Jun 12 2018 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 31,291 | 0 | 74,989 | 43.7 K to 75 K (+71.61 %) |
Jun 04 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 6.43 | 1,555 | 9,999 | 39,702 | 38.1 K to 39.7 K (+4.08 %) |
Mar 02 2018 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.97 | 2,012 | 10,000 | 38,147 | 36.1 K to 38.1 K (+5.57 %) |
Dec 04 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.08 | 1,968 | 9,997 | 36,135 | 34.2 K to 36.1 K (+5.76 %) |
Sep 05 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.10 | 1,960 | 9,996 | 34,167 | 32.2 K to 34.2 K (+6.09 %) |
Jun 12 2017 | ENDP | Endo International ... | Hutson Nancy J | Director | Payment of Exercise | F | 11.49 | 11,488 | 131,997 | 43,698 | 55.2 K to 43.7 K (-20.82 %) |
Jun 12 2017 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 23,934 | 0 | 55,186 | 31.3 K to 55.2 K (+76.58 %) |
Jun 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.15 | 1,941 | 9,996 | 32,207 | 30.3 K to 32.2 K (+6.41 %) |
May 25 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 5.13 | 30,000 | 153,900 | 30,000 | |
Mar 10 2017 | ENDP | Endo International ... | Hutson Nancy J | Director | Sell | S | 10.82 | 5,325 | 57,617 | 31,252 | 36.6 K to 31.3 K (-14.56 %) |
Mar 02 2017 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 6.24 | 1,602 | 9,996 | 30,266 | 28.7 K to 30.3 K (+5.59 %) |
Dec 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 5.59 | 1,788 | 9,995 | 28,664 | 26.9 K to 28.7 K (+6.65 %) |
Sep 06 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 4.11 | 2,433 | 10,000 | 26,876 | 24.4 K to 26.9 K (+9.95 %) |
Jun 02 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 3.39 | 2,581 | 8,750 | 24,443 | 21.9 K to 24.4 K (+11.81 %) |
May 25 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 3.22 | 30,000 | 96,600 | 30,000 | |
Mar 03 2016 | ENDP | Endo International ... | Hutson Nancy J | Director | Sell | S | 42.19 | 3,413 | 143,994 | 36,577 | 40 K to 36.6 K (-8.53 %) |
Mar 03 2016 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 7,111 | 0 | 39,990 | 32.9 K to 40 K (+21.63 %) |
Mar 01 2016 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 1.99 | 4,396 | 8,748 | 21,862 | 17.5 K to 21.9 K (+25.17 %) |
Dec 03 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 10.61 | 824 | 8,743 | 17,466 | 16.6 K to 17.5 K (+4.95 %) |
Sep 02 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Grant | A | 11.64 | 751 | 8,742 | 16,642 | 15.9 K to 16.6 K (+4.73 %) |
May 22 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Option Exercise | A | 11.39 | 15,000 | 170,850 | 15,000 | |
Mar 06 2015 | ENDP | Endo International ... | Hutson Nancy J | Director | Grant | A | 0.00 | 3,436 | 0 | 32,879 | 29.4 K to 32.9 K (+11.67 %) |
Feb 23 2015 | BCRX | BIOCRYST PHARMACEU ... | Hutson Nancy J | Director | Buy | P | 10.27 | 10,000 | 102,700 | 15,891 | 5.9 K to 15.9 K (+169.75 %) |
Nov 12 2010 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Buy | P | 6.99 | 5,400 | 37,746 | 14,800 | 9.4 K to 14.8 K (+57.45 %) |
Nov 12 2010 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Buy | P | 6.98 | 1,600 | 11,168 | 9,400 | 7.8 K to 9.4 K (+20.51 %) |
Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 0.00 | 6,873 | 0 | 6,873 | |
Jun 07 2010 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.82 | 10,164 | 59,154 | 10,164 | |
Jun 09 2009 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.05 | 30,000 | 151,500 | 30,000 | |
Jun 12 2008 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.00 | 30,000 | 150,000 | 30,000 | |
Jun 12 2007 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.46 | 30,000 | 163,800 | 30,000 | |
Mar 13 2007 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Buy | P | 6.35 | 7,800 | 49,529 | 7,800 | 0 to 7.8 K |
Oct 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.40 | 1,333 | 7,198 | 1,333 | |
Oct 30 2006 | ISPH | INSPIRE PHARMACEUT ... | Hutson Nancy J | Director | Option Exercise | A | 5.40 | 17,778 | 96,001 | 17,778 |
Page: 1